S2E5: CV Risk Reduction in the Era of PCSK9 Inhibitors

Dr. Alan Brown sits down with Kim Birtcher, PharmD, CLS, FNLA, Adjunct Clinical Professor at the University of Houston College of Pharmacy, to discuss approaches to cardiovascular risk reduction in the age of modern therapies such as PCSK9 inhibitors.

Recent Podcasts

S2E5: Practical Approaches to Cardiovascular Risk Reduction in the Era of PCSK9 Inhibitors

Host

Guest

Recent Podcasts

Episode 6: Industry Innovations: Guidelines in Action

Episode 5: Statin Intolerance in Focus: Navigating Side Effects, Patient Concerns, and the Path to Optimal LDL Lowering

S7E8: Thinking Long-Term: LDL Exposure, Longevity Medicine, and the Future of Cardiovascular Prevention

S1E1: Clinical Pearls on Provider Methods for Obtaining Prior Authorizations for PCSK9i

S1E2: General Gaps in FH Care